DH Definitive Healthcare Corp.
Services-Prepackaged Software · Nasdaq · SEC CIK 1861795 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-6.2%
TTM net income YoY16.7%
TTM EPS YoY12.8%
Revenue 3-yr CAGR-2.6%
Net income 3-yr CAGR—
Margins
Gross margin75.4%
Operating margin-105.4%
Net margin-69.2%
FCF margin10.6%
EBITDA margin-96.9%
Returns
ROE-73.1%
ROA-25.3%
ROIC (approx.)-80.5%
Asset turnover0.37x
Leverage & solvency
Liabilities / assets61.4%
Debt / equity1.09x
Current ratio1.96x
Interest coverage-22.22x
Cash quality & payout
Operating cash flow / net income-0.24x
Accruals ratio-31.3%
Payout ratio—
Capex / revenue5.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $241.52M | $252.20M | $251.41M | $222.65M | $166.15M |
| Cost of revenue | $58.25M | $54.73M | $47.48M | $42.62M | $19.42M |
| Gross profit | $183.28M | $197.47M | $203.93M | $180.03M | $125.47M |
| R&D expense | $34.78M | $36.52M | $42.44M | $34.89M | $18.57M |
| SG&A expense | $51.63M | $49.27M | $58.86M | $51.56M | $32.86M |
| Operating income | -$224.27M | -$710.82M | -$329.80M | -$44.04M | -$27.32M |
| Interest expense | $11.29M | $14.84M | $15.20M | $11.20M | $25.90M |
| Pretax income | -$209.26M | -$633.75M | -$308.18M | -$41.88M | -$62.77M |
| Income tax | -$9.96M | -$42.30M | -$18.55M | -$17.70M | -$443,000 |
| Net income | -$138.93M | -$413.12M | -$202.39M | -$7.22M | -$17.84M |
| EBITDA | -$220.97M | -$708.58M | -$327.85M | -$41.85M | -$25.57M |
| EPS (basic) | -1.30 | -3.54 | -1.79 | -0.07 | -0.19 |
| EPS (diluted) | -1.30 | -3.54 | -1.79 | -0.07 | -0.19 |
| Weighted avg. shares (diluted) | 106.65M | 116.64M | 112.76M | 101.11M | 91.92M |
| Balance sheet | |||||
| Cash & equivalents | $163.63M | $105.38M | $130.98M | $146.93M | $387.50M |
| Short-term investments | $17.26M | $184.79M | $177.09M | $184.94M | $0 |
| Receivables | $51.98M | $53.20M | $59.25M | $58.80M | $43.34M |
| Current assets | $257.61M | $370.17M | $393.93M | $413.75M | $444.23M |
| PP&E, net | $12.68M | $3.79M | $4.47M | $4.46M | $5.07M |
| Goodwill | $197.22M | $393.28M | $1.08B | $1.32B | $1.26B |
| Intangibles | $247.48M | $297.93M | $323.12M | $350.72M | $352.47M |
| Total assets | $735.49M | $1.09B | $1.83B | $2.12B | $2.12B |
| Current liabilities | $156.79M | $161.16M | $170.68M | $140.61M | $123.12M |
| Short-term debt | $8.75M | $13.75M | $13.75M | $8.59M | $6.88M |
| Long-term debt | $156.09M | $229.37M | $242.57M | $255.76M | $263.81M |
| Total debt | $164.84M | $243.12M | $256.32M | $264.36M | $270.68M |
| Total liabilities | $356.50M | $482.19M | $626.73M | $640.68M | $617.78M |
| Shareholders' equity | $281.11M | $444.38M | $861.36M | $948.92M | $871.31M |
| Net debt | $1.21M | $137.74M | $125.34M | $117.42M | -$116.81M |
| Cash flow statement | |||||
| Operating cash flow | $53.78M | $58.20M | $41.19M | $35.58M | $25.21M |
| Capital expenditure | $16.72M | $12.34M | $2.98M | $8.33M | $6.73M |
| Free cash flow | $37.06M | $45.85M | $38.21M | $27.25M | $18.48M |
| Investing cash flow | $153.88M | -$26.41M | -$31.78M | -$248.90M | -$46.73M |
| Financing cash flow | -$150.79M | -$56.75M | -$25.58M | -$26.70M | $384.37M |
| Depreciation & amortization | $3.30M | $2.25M | $1.95M | $2.19M | $1.75M |
| Stock-based compensation | $29.14M | $38.09M | $48.74M | $36.43M | $9.96M |
| Share buybacks | $49.45M | $22.37M | $0 | $0 | — |
Free plan shows the latest 5 periods; Pro shows all 7 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.